Arvin Yang
2021
Compensation breakdown
| Non-Equity Incentive Plan | $201,960 |
|---|---|
| Salary | $510,000 |
| Other | $157,000 |
| Total | $868,960 |
Yang received $510K in salary, accounting for 59% of the total pay in 2021.
Yang also received $202K in non-equity incentive plan and $157K in other compensation.
Rankings
In 2021, Arvin Yang's compensation ranked 9,231st out of 12,415 executives tracked by ExecPay. In other words, Yang earned more than 25.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,231 out of 12,415 | 26th |
Division Manufacturing | 4,093 out of 5,501 | 26th |
Major group Chemicals And Allied Products | 1,803 out of 2,371 | 24th |
Industry group Drugs | 1,603 out of 2,092 | 23rd |
Industry Pharmaceutical Preparations | 1,188 out of 1,542 | 23rd |
Pay ratio
| Arvin Yang's Pay | $868,960 |
|---|---|
| Median Employee's Pay | $302,642 |
| Pay Ratio | to 1 |
In 2021, the annual total compensation of Arvin Yang was $868,960.
The annual total compensation of the median employee at Mersana Therapeutics was $302,642.
The ratio of Arvin Yang's pay to the pay of median employee was therefore to one.
Yang's colleagues
We found six more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2021.
2021
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2021
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2021
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2021
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
2021
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2021
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021